AstraZeneca signs $555mn AI deal to develop gene&editing therapies (Financial Times)
Financial Times: AstraZeneca signs $555mn AI deal to develop gene-editing therapies — Pharmaceutical company is latest to invest in artificial intelligence to speed drug development — AstraZeneca has signed a $555mn deal with a San Francisco-based biotech business that specialises in artificial intelligence …
Financial Times:
AstraZeneca signs $555mn AI deal to develop gene-editing therapies — Pharmaceutical company is latest to invest in artificial intelligence to speed drug development — AstraZeneca has signed a $555mn deal with a San Francisco-based biotech business that specialises in artificial intelligence …
